Moises Leon-Ruiz | Neuroscience | Best Researcher Award

Dr. Moises Leon-Ruiz | Neuroscience | Best Researcher Award

Neurology | Hospital University Sivero Ochoa | Spain

Dr. Moises Leon-Ruiz is a neurologist with advanced training in neurophysiology and clinical neurology, having completed his medical degree, followed by specialization and fellowships in neurology and neurosciences. He holds a Ph.D. in Neuroscience, having conducted his doctoral work at a well-reputed university, focusing on neurodegenerative disease models and neuroinflammation. His professional experience spans positions in university hospitals and clinical research centers, where he has served both as a clinician seeing patients and as a researcher in translational neuroscience laboratories. Dr. Moises Leon-Ruiz has authored 71 documents, 147 Citations, 6 h-index, demonstrating his performance in scholarly publishing. His research interests include Alzheimer’s disease, induced pluripotent stem cell (iPSC) models, clinical neuroimmunology, and biomarkers of neurological disorders. He has skills in molecular biology (gene editing, PSEN1 mutation correction), stem cell biology, neurophysiological assessment, imaging, and computational/statistical analysis. He has participated in international collaborative research projects, including isogenic iPSC line generation from Alzheimer’s disease patients. Dr. Moises Leon-Ruiz has been recognized with honors such as awards from neurology societies, invitations to speak at international symposia, and membership or roles in professional organisations in neurology.

Dr. Moises Leon-Ruiz demonstrates a strong and growing profile combining clinical neurology, stem cell-based disease modeling, and molecular neuroscience. His publication record and research skills show that he is well positioned to continue making meaningful contributions to understanding neurodegenerative disease mechanisms, translating findings into clinical impact, and mentoring the next generation of researchers.

Profile:  Scopus

Featured Publications

  1. Generation of a gene-corrected human isogenic iPSC line from an Alzheimer’s disease iPSC line carrying the PSEN1 H163R mutation — 2024

  2. “Wine Glass” sign following COVID-19 vaccination in a previously healthy adult — 2022

  3. Cerebral Venous Thrombosis as The Sole Presenting Manifestation of Human Immunodeficiency Virus and Hepatitis B Virus Co-Infection — 2022

  4. PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer’s Disease — 2017

  5. Babinski’s Lost Legacy: A Remarkable Case of a Not-So-New Clinical Construct — 2016

 

Kaouthar Louati | Neuroscience | Excellence in Research Award

Kaouthar Louati | Neuroscience | Excellence in Research Award

Dr Kaouthar Louati, University of Monastir, Tunisia

Dr. Kaouthar Louati is a distinguished researcher and analytical chemist 🎓🧪 with a doctoral degree in Analytical Chemistry from the University of Monastir, Tunisia 🇹🇳. She has made substantial contributions to pharmaceutical sciences through over 15 high-impact publications 📚, two book contributions 📘, and collaborative projects in Tunisia and the UK 🇬🇧. Her work focuses on toxicoproteomics, redox proteomics, and stability studies of pharmaceuticals 💊. Dr. Louati is affiliated with prestigious institutions including the University of Nottingham, Habib Bourguiba University Hospital, and multiple pharmaceutical laboratories 🏥🔬. Known for her meticulous method validation, drug impurity analysis, and environmental toxicology studies 🌿⚗️, she has emerged as a key figure in analytical method development and toxicological risk assessment. With deep academic commitment and a passion for pharmaceutical innovation 💡, she continues to impact the global scientific community and serves as a role model for women in STEM 👩‍🔬🌍.

Publication Profile

Orcid

Education

Dr. Louati’s academic journey is rooted in excellence 🌟. She earned her Doctorate in Analytical Chemistry (2019–2024) 🧪 from the University of Monastir, Tunisia, with very honorable distinction 🎓. Previously, she completed a Master’s in Medicaments’ Research and Development (2009–2010) 🧬 and a Diploma in Doctor of Pharmacy (2008–2009), both with high honors 🏅. Her early academic path included a Diploma in Pharmacy (2002–2007) with a very good grade 🧑‍⚕️ and a Mathematics Baccalaureate (2002) with very honorable mention 🧠➕➖. Throughout her education, she displayed strong scientific aptitude, particularly in pharmaceutical formulation, analytical chemistry, and medical science fundamentals 💉📘. This rich academic foundation positioned her to excel in multidisciplinary pharmaceutical research, bridging clinical applications with laboratory innovation 🧫🔍.

Experience

Dr. Louati has extensive experience in academia, hospitals, and the pharmaceutical industry 🏥🏭. Since 2020, she has served as a Doctor Pharmacist and Associate Researcher at the University of Monastir’s Laboratory of Pharmacology and Drug Development 🔬, and at the Habib Bourguiba University Hospital in both the pharmaceutical and pathological anatomy departments 🧑‍⚕️🧫. She also contributed internationally at the University of Nottingham and Royal Derby Hospital, UK (2020–2023) 🇬🇧. From 2010 to 2015, she worked in UNIMED and PHARMACARE Laboratories, where she developed generic drugs, validated analytical methods, and ensured product compliance with international pharmacopeias 💊📈. Her expertise spans method validation (ICH Q2R1), stress testing, impurity profiling, and regulatory documentation ✍️📑. Her collaborative approach and technical leadership across diverse settings underscore her excellence as both a researcher and pharmaceutical scientist 🌍🧪.

Awards and Honors

Dr. Kaouthar Louati has earned academic distinction throughout her career, including “Very Honorable” mentions for both her doctoral and master’s studies 🏅📘. She was recognized for producing highly cited research and has published over 15 peer-reviewed articles and 2 books in respected international journals and editions 📚🌐. Her contributions to method development, toxicological evaluation, and environmental health have received national and international attention 🧬🌍. Her scientific rigor earned her opportunities to collaborate with global institutions such as the University of Nottingham, reflecting peer recognition and trust in her expertise 🤝🔬. Her work on toxicoproteomics and pharmaceutical impurities has made significant impacts on public health research and regulatory science 🌡️⚗️. Dr. Louati’s continued academic excellence, innovation, and mentorship potential position her as a prime candidate for the Best Researcher Award 🏆🎖️.

Research Focus

Dr. Louati’s research is at the forefront of analytical chemistry, toxicoproteomics, and pharmaceutical sciences 🔍🧪. She focuses on validating and developing robust analytical methods to detect drug impurities, residual solvents, and degradation products, essential for drug stability and safety studies 💊📈. Her work in toxicoproteomics includes assessing oxidative stress and protein damage induced by environmental toxins like pesticides using cutting-edge techniques like Nano-UHPLC-MS/MS and 2D-SDS-PAGE 🌿🧬. She also pioneers method development for anti-epileptic drug monitoring and anabolic steroid detection for doping control 🧠💪. Her integration of redox biology and pharmacological analytics strengthens both environmental health surveillance and clinical pharmacology 🌎🏥. Dr. Louati’s unique blend of expertise bridges fundamental research with real-world applications, significantly contributing to public health, pharmacovigilance, and regulatory standards 🌐📊.

Publication Top Notes

A Shotgun Proteomic-Based Approach with a Q-Exactive Hybrid Quadrupole-Orbitrap High-Resolution Mass Spectrometer for the Assessment of Pesticide Mixture-Induced Neurotoxicity on a 3D-Developed Neurospheroid Model from Human Brain Meningiomas: Identification of Trityl-Post-Translational Modification

ELENI KONSTANTINOPOULOU | Neuroscience | Best Researcher Award

ELENI KONSTANTINOPOULOU | Neuroscience | Best Researcher Award

Dr ELENI KONSTANTINOPOULOU, ARISTOTLE UNIVERSITY OF THESSALONIKI, Greece

Dr. Eleni Konstantinopoulou is a distinguished Psychologist 🧑‍⚕️ with expertise in Neuropsychology 🧬. She earned her M.Sc. in Cognitive Psychology in 2010 and completed her Ph.D. in Neuropsychology in 2019 at the Aristotle University of Thessaloniki 🇬🇷. Her prolific research focuses on cognitive and psychological processes affected by neurological conditions, especially Frontotemporal Dementia 🧠. With over a decade of contributions at the 2nd Department of Neurology, she has led and supported numerous research projects in neuropsychology, cognitive psychology, and distance education 📚. Dr. Konstantinopoulou has been both an academic scholar and clinical researcher, blending education and practice seamlessly. She actively contributes to the scientific community through publications, lectures, and collaborations 🔬. Her work exemplifies excellence, innovation, and dedication to advancing brain health and cognitive rehabilitation 💡.

Publication Profile

Google Scholar

Education

Dr. Eleni Konstantinopoulou graduated with a degree in Psychology from the School of Psychology, Faculty of Philosophy at Aristotle University of Thessaloniki 🎓. She pursued her postgraduate studies in Cognitive Psychology, obtaining a Master of Science degree in 2010 📘. Her intellectual passion led her to doctoral studies, culminating in a Ph.D. in Neuropsychology in 2019 🧪. During her academic journey, she honed her specialization in the neuropsychological impacts of degenerative brain disorders, with a specific focus on Frontotemporal Dementia 🧠. Her education has been marked by academic excellence, cross-disciplinary training, and a commitment to bridging the gap between cognitive theory and clinical application 📖🔍. Through continuous professional development and scholarly work, she has contributed to shaping future professionals and enhancing evidence-based practices in neuropsychology.

Experience

With over 14 years of combined clinical and academic experience, Dr. Konstantinopoulou has been a clinical and research fellow at the 2nd Department of Neurology at Aristotle University of Thessaloniki (2010–2024) 🏥🔬. She contributed as a research assistant and coordinator in various clinical trials and cognitive rehabilitation programs. Her teaching career includes roles as academic scholar at the University of Western Macedonia and Aristotle University, training future psychologists and clinicians 👩‍🏫📘. She has led neuropsychological assessments, contributed to diagnostic tools, and collaborated on multidisciplinary research involving MS and dementia. As a member of the Hellenic Neuropsychological Society 🧠🇬🇷, she continues to advocate for clinical excellence and scientific advancement. Her postdoctoral research (2019–2024) explored neuroanatomical correlations in Frontotemporal Dementia, further establishing her as a leader in the field. Her professional portfolio reflects depth, dedication, and impact across healthcare and academia 🧑‍⚕️📚.

Awards & Honors

Dr. Eleni Konstantinopoulou’s work has received growing recognition in the domains of neuropsychology and cognitive rehabilitation 🧠🏅. While formal national or international awards are not listed, her impactful publications in high-ranking journals and her long-standing research collaboration in prominent neurology departments position her as an ideal candidate for the Best Researcher Award 🥇📈. Her involvement in the adaptation of Addenbrooke’s Cognitive Examination-Revised for Greek populations is highly cited and influential 🇬🇷📊. Her role in the IGNITE study and other MS-related cognitive research further reflects her ability to bridge clinical practice with scientific inquiry 🌐. She is respected in the Hellenic Neuropsychological Society and frequently collaborates on studies published in journals such as European Journal of Neurology, International Journal of Geriatric Psychiatry, and Journal of Neurological Sciences 📑🌟. Her track record of excellence and collaborative spirit make her a standout candidate.

Research Focus

Dr. Konstantinopoulou’s research centers on the interplay between neurodegenerative diseases and cognitive function 🧠📉. Her primary interest lies in understanding how conditions like Frontotemporal Dementia (FTD) and Multiple Sclerosis (MS) affect memory, executive function, behavior, and psychological well-being 🧪🧍‍♀️. She has explored neuropsychological profiles of different FTD variants, helping clinicians refine diagnoses and tailor interventions. Her postdoctoral work involved neuroanatomical mapping to link behavioral symptoms with structural brain changes using neuroimaging 🧬🧠. She also engages in cognitive rehabilitation, testing computerized tools to improve MS patients’ cognitive abilities 💻🧑‍⚕️. Her contributions to the adaptation of diagnostic tools like ACE-R for the Greek population enhance cross-cultural assessment and clinical accuracy 🇬🇷📝. Overall, her research supports early detection, better classification, and targeted cognitive therapies in neurology, impacting both clinical outcomes and scientific knowledge 🌍📊.

Publication Top Notes

Adaptation of Addenbrooke’s cognitive examination‐revised for the Greek population

The rationale for monitoring cognitive function in multiple sclerosis: practical issues for clinicians

Computerized cognitive rehabilitation for treatment of cognitive impairment in multiple sclerosis: an explorative study.

Behavioral disturbances differentiate frontotemporal lobar degeneration subtypes and Alzheimer’s disease: evidence from the Frontal Behavioral Inventory

The frontotemporal dementias in a tertiary referral center: classification and demographic characteristics in a series of 232 cases

Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study

Early onset degenerative dementias: demographic characteristics and etiologic classification in a tertiary referral center

Changes in children’s beliefs about everyday reasoning: Evidence from Greek primary students.